Clinical trial
Pancreatic Islet Cell Transplantation
NCT00214786 · Baylor Research Institute, Other · Completed
Key facts
| NCT number | NCT00214786 |
|---|---|
| Title | Pancreatic Islet Cell Transplantation |
| Official title | Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression and Validation of Remote Site Islet Cell Processing, Islet Cell Culture and Two-Layer Preservation |
| Lead sponsor | Baylor Research Institute, Other |
| Collaborators | Baylor Health Care System University of Miami |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Biological |
| Interventions | Islet cell transplantation |
| Enrollment | 4 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: